Marcin Waligora
Marcin Waligora
Professor at Jagiellonian University Medical College
E-mail megerősítve itt: uj.edu.pl - Kezdőlap
Hivatkozott rá
Hivatkozott rá
Evaluating Progression-Free Survival as a Surrogate Outcome for Health-Related Quality of Life in Oncology: A Systematic Review and Quantitative Analysis
B Kovic, X Jin, SA Kennedy, M Hylands, M Pędziwiatr, A Kuriyama, ...
JAMA Internal Medicine, 2018
Google Search as an Additional Source in Systematic Reviews
J Piasecki, M Waligora, V Dranseika
Science and Engineering Ethics, 2017
Research in disaster settings: a systematic qualitative review of ethical guidelines
S Mezinska, P Kakuk, G Mijaljica, M Waligóra, D O'Mathúna
BMC Medical Ethics 17 (62), 1-11, 2016
A systematic review on how patients value chronic obstructive pulmonary disease outcomes
Y Zhang, RL Morgan, P Alonso-Coello, W Wiercioch, MM Bała, ...
European Respiratory Journal, 2018
Child’s assent in research: Age threshold or personalisation?
M Waligora, V Dranseika, J Piasecki
BMC medical ethics 15, 1-7, 2014
Umbrella and basket trials in oncology: ethical challenges
K Strzebonska, M Waligora
BMC Medical Ethics 20, 2019
Risk and surrogate benefit for pediatric phase I trials in oncology: a systematic review with meta-analysis
M Waligora, MM Bala, M Koperny, MT Wasylewski, K Strzebonska, ...
PLoS medicine 15 (2), e1002505, 2018
Relevant Information and Informed Consent in Research: In Defense of the Subjective Standard of Disclosure
V Dranseika, J Piasecki, M Waligora
Science and Engineering Ethics, 1-11, 2016
Publication Ethics in Biomedical Journals from Countries in Central and Eastern Europe
M Broga, G Mijaljica, M Waligora, A Keis, A Marusic
Science and Engineering Ethics, Springer, 2013
What Do Ethical Guidelines for Epidemiology Say About an Ethics Review? A Qualitative Systematic Review
J Piasecki, M Waligora, D Vilius
Science and Engineering Ethics 23 (3), 743–768, 2017
Wstęp do fenomenologii
M Waligóra
Towarzystwo Autorów i Wydawców Prac Naukowych UNIVERSITAS, 2013
Forensic uses of research biobanks: should donors be informed?
V Dranseika, J Piasecki, M Waligora
Medicine, Health Care and Philosophy, 1-6, 2015
Non-beneficial pediatric research: individual and social interests
J Piasecki, M Waligora, V Dranseika
Medicine, Health Care and Philosophy 18, 103-112, 2015
Results dissemination of registered clinical trials across Polish academic institutions: a cross-sectional analysis
K Strzebonska, MT Wasylewski, L Zaborowska, N Riedel, S Wieschowski, ...
BMJ Open, 2020
Failures in clinical trials in the European Union: Lessons from the Polish experience
M Waligora
Science and engineering ethics 19, 1087-1098, 2013
Participant protection in phase 1 pediatric cancer trials
J Kimmelman, M Waligora, HF Lynch
JAMA pediatrics 173 (1), 8-9, 2019
Is a requirement of personalised assent realistic? A case from the GABRIEL project
M Waligora
European Journal of Human Genetics, 2013
Child’s objection to non-beneficial research: capacity and distress based models
M Waligora, J Różyńska, J Piasecki
Medicine, Health Care and Philosophy 19, 65-70, 2016
A European consistency for functioning of RECs? We just lost our chance
M Waligora
Journal of Medical Ethics 39 (6), 408-409, 2013
Neither the harm principle nor the best interest standard should be applied to pediatric research
M Waligora, K Strzebonska, MT Wasylewski
The American Journal of Bioethics 18 (8), 72-74, 2018
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20